Gilead Sciences, Inc.
USD128.99
+1.42 (+1.11%)
CEO
Daniel O'Day
IPO Date
1992-01-22
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NASDAQ
Country
US
Open
$127.59
Prev. Close
$127.57
Day Low
$127.50
Day High
$129.86
52W Low
$104.46
52W High
$157.29
Market Cap
$160.15B
Volume
6.21M
| 240.0 |
| 31 Dec 2023 | FY | 76.0% | 20.9% | 24.8% | 9.1% | 1.09 | 1.43 | 17.8 |
| 31 Dec 2022 | FY | 79.3% | 16.8% | 21.7% | 7.3% | 1.19 | 1.36 | 23.5 |
| 31 Dec 2021 | FY | 75.8% | 22.8% | 29.6% | 9.2% | 1.27 | 1.30 | 14.7 |
| 31 Dec 2020 | FY | 81.5% | 0.4% | 0.5% | 0.1% | 1.72 | 1.39 | 822.8 |
| 31 Dec 2019 | FY | 79.2% | 24.0% | 23.8% | 8.7% | 1.09 | 3.23 | 15.3 |
| 31 Dec 2018 | FY | 78.1% | 24.7% | 25.3% | 8.6% | 1.27 | 3.36 | 14.9 |
| 31 Dec 2017 | FY | 83.3% | 17.7% | 22.6% | 6.6% | 1.64 | 3.55 | 20.2 |
| 31 Dec 2016 | FY | 86.0% | 44.4% | 69.7% | 23.7% | 1.29 | 4.17 | 7.1 |
| 11.3 |
| 30 Jun 2025 | Q2 | 78.8% | 27.7% | 10.0% | 3.5% | 1.27 | 1.32 | 17.6 |
| 31 Mar 2025 | Q1 | 76.9% | 19.7% | 6.9% | 2.3% | 1.30 | 1.37 | 26.5 |
| 31 Dec 2024 | Q4 | 79.1% | 23.6% | 9.2% | 3.0% | 1.38 | 1.60 | 16.2 |
| 30 Sept 2024 | Q3 | 79.1% | 16.6% | 6.8% | 2.3% | 1.26 | 1.26 | 20.9 |
| 30 Jun 2024 | Q2 | 77.8% | 23.2% | 8.8% | 3.0% | 1.28 | 1.14 | 13.3 |
| 31 Mar 2024 | Q1 | 76.8% | -62.4% | -23.8% | -7.4% | 1.44 | 1.08 | -5.4 |
| 31 Dec 2023 | Q4 | 78.1% | 20.1% | 6.3% | 2.3% | 1.10 | 1.46 | 17.7 |
| 30 Sept 2023 | Q3 | 77.8% | 30.9% | 9.8% | 3.5% | 1.16 | 1.34 | 10.7 |